Brasilia,Brazil——Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort EP") obtained the regulatory approval by Brazil ANVISA for its independently developed FireMagic™ Irrigated Ablation Catheter and FireMagic™ 3D Irrigated Ablation Catheter.
Arrhythmia is a common disease of cardiovascular diseases, and RF ablation is an important treatment for arrhythmia. The FireMagic™ ablation catheters can be used in conjunction with radiofrequency ablation generator for the treatment of tachyarrhythmias with clear clinical symptoms and electrocardiographic evidence, including AVRT and AVNRT.
The approval of the FireMagic™ Irrigated Ablation Catheter and FireMagic™ 3D Irrigated Ablation Catheter by Brazil ANVISA enriches and improves MicroPort EP product line in Brazil,which lays a solid groundwork for the company’s further exploration in South America market.
In the future, MicroPort EP will continue to build a differentiated product portfolio and expand its global reach, offering comprehensive solutions for diagnosis and therapy of EP interventions for doctors and patients worldwide.